Literature DB >> 19366371

Expression of COUP-TF-interacting protein 2 (CTIP2) in human atopic dermatitis and allergic contact dermatitis skin.

Gitali Ganguli-Indra, Xiaobo Liang, Stephen Hyter, Mark Leid, Jon Hanifin, Arup K Indra.   

Abstract

Chicken ovalbumin upstream promoter-transcription factor-interacting protein 2 (CTIP2) is a transcriptional regulator that is highly expressed in skin during mouse development, as well as in proliferating cells of adult mouse skin. We investigated expression of CTIP2 along with proliferation marker Ki-67 in normal human skin, and in skin from atopic dermatitis (AD), and in allergic contact dermatitis (ACD) samples by immunohistochemistry (IHC). We discovered for the first time that CTIP2 was expressed in proliferating basal and suprabasal layer in normal human epidermis. CTIP2 expression was dramatically increased in the epidermis from the AD and ACD samples compared with normal samples, and was labelled in both proliferating basal and suprabasal layers. Altogether our results suggest that CTIP2 expression could be linked to disease progression and/or maintenance in AD and ACD patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19366371      PMCID: PMC2783464          DOI: 10.1111/j.1600-0625.2009.00876.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  23 in total

1.  Isolation of a novel family of C(2)H(2) zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors.

Authors:  D Avram; A Fields; K Pretty On Top; D J Nevrivy; J E Ishmael; M Leid
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

Review 2.  Skin lipids and epidermal differentiation in atopic dermatitis.

Authors:  Ehrhardt Proksch; Jens-Michael Jensen; Peter M Elias
Journal:  Clin Dermatol       Date:  2003 Mar-Apr       Impact factor: 3.541

3.  Bcl11b is required for differentiation and survival of alphabeta T lymphocytes.

Authors:  Yuichi Wakabayashi; Hisami Watanabe; Jun Inoue; Naoki Takeda; Jun Sakata; Yukio Mishima; Jiro Hitomi; Takashi Yamamoto; Masanori Utsuyama; Ohtsura Niwa; Shinichi Aizawa; Ryo Kominami
Journal:  Nat Immunol       Date:  2003-04-28       Impact factor: 25.606

4.  Proliferative processes in the epidermis of patients with atopic dermatitis treated with thymodepressin.

Authors:  S G Sapuntsova; N P Mel'nikova; V I Deigin; E A Kozulin; S S Timoshin
Journal:  Bull Exp Biol Med       Date:  2002-05       Impact factor: 0.804

Review 5.  The Ki-67 protein: from the known and the unknown.

Authors:  T Scholzen; J Gerdes
Journal:  J Cell Physiol       Date:  2000-03       Impact factor: 6.384

6.  CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis.

Authors:  Mark Leid; Jane E Ishmael; Dorina Avram; David Shepherd; Valérie Fraulob; Pascal Dollé
Journal:  Gene Expr Patterns       Date:  2004-10       Impact factor: 1.224

7.  MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis.

Authors:  G Ganguli; J Abecassis; B Wasylyk
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

Review 8.  Atopic dermatitis.

Authors:  Donald Y M Leung; Thomas Bieber
Journal:  Lancet       Date:  2003-01-11       Impact factor: 79.321

Review 9.  New insights into atopic dermatitis.

Authors:  Donald Y M Leung; Mark Boguniewicz; Michael D Howell; Ichiro Nomura; Qutayba A Hamid
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

10.  COUP-TF (chicken ovalbumin upstream promoter transcription factor)-interacting protein 1 (CTIP1) is a sequence-specific DNA binding protein.

Authors:  Dorina Avram; Andrew Fields; Thanaset Senawong; Acharawan Topark-Ngarm; Mark Leid
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

View more
  8 in total

Review 1.  CTIP2 and lipid metabolism: regulation in skin development and associated diseases.

Authors:  Nilika Bhattacharya; Gitali Ganguli-Indra; Arup K Indra
Journal:  Expert Rev Proteomics       Date:  2021-11-17       Impact factor: 4.250

2.  Delayed cutaneous wound healing and aberrant expression of hair follicle stem cell markers in mice selectively lacking Ctip2 in epidermis.

Authors:  Xiaobo Liang; Shreya Bhattacharya; Gaurav Bajaj; Gunjan Guha; Zhixing Wang; Hyo-Sang Jang; Mark Leid; Arup Kumar Indra; Gitali Ganguli-Indra
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

Review 3.  Using mouse models to study function of transcriptional factors in T cell development.

Authors:  Peng Li; Yiren Xiao; Zhixin Liu; Pentao Liu
Journal:  Cell Regen (Lond)       Date:  2012-10-10

Review 4.  Bcl11b-A Critical Neurodevelopmental Transcription Factor-Roles in Health and Disease.

Authors:  Matthew J Lennon; Simon P Jones; Michael D Lovelace; Gilles J Guillemin; Bruce J Brew
Journal:  Front Cell Neurosci       Date:  2017-03-29       Impact factor: 5.505

Review 5.  Bcl11b/Ctip2 in Skin, Tooth, and Craniofacial System.

Authors:  Marie-Thérèse Daher; Pedro Bausero; Onnik Agbulut; Zhenlin Li; Ara Parlakian
Journal:  Front Cell Dev Biol       Date:  2020-12-10

Review 6.  Bioengineered Efficacy Models of Skin Disease: Advances in the Last 10 Years.

Authors:  Diana Nicole Stanton; Gitali Ganguli-Indra; Arup Kumar Indra; Pankaj Karande
Journal:  Pharmaceutics       Date:  2022-01-28       Impact factor: 6.321

7.  CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status.

Authors:  Gitali Ganguli-Indra; Christine Wasylyk; Xiaobo Liang; Regine Millon; Mark Leid; Bohdan Wasylyk; Joseph Abecassis; Arup K Indra; Arup Indra
Journal:  PLoS One       Date:  2009-04-28       Impact factor: 3.240

8.  Selective ablation of Ctip2/Bcl11b in epidermal keratinocytes triggers atopic dermatitis-like skin inflammatory responses in adult mice.

Authors:  Zhixing Wang; Ling-Juan Zhang; Gunjan Guha; Shan Li; Kateryna Kyrylkova; Chrissa Kioussi; Mark Leid; Gitali Ganguli-Indra; Arup K Indra
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.